13.19 USD
↗ 1.44 (12.26%)AT CLOSE (11:59 AM EDT)
SELLAS Life Sciences Group, Inc. Common Stock
SLSNASDAQ • USD
13.33
↗ 0.13 (1.02%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
13.33
↗ 0.13 (1.02%)
Market: CLOSED
SELLAS Life Sciences Group, Inc. Common Stock (SLS) trades at $13.17 per share. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Furthermore, SLS is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Jul 17, 2026.
Open?$11.65
High?$13.54
Low?$11.40
Prev. Close?$11.75
Volume?11.3M
Avg. Volume?9.9M
VWAP?$12.98
Rel. Volume?1.14x
Bid / Ask
Bid?$11.42 × 100
Ask?$15.05 × 100
Spread?$3.63
Midpoint?$13.24
Valuation & Ratios
Market Cap?2.3B
Shares Out?196.6M
Float?183.6M
Float %?98.7%
P/E Ratio?N/A
P/B Ratio?21.51
EPS?-$0.15
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
Themes
Employees
13
Market Cap
2.3B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2008-03-12
Address
7 TIMES SQUARE
NEW YORK, NY 10036
Phone: (646) 200-5278
NEW YORK, NY 10036
Phone: (646) 200-5278
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?65
Short Sent.?42
Piotroski F-Score?0/9Weak
Altman Z-Score?201.63Safe
Confidence?49%Low
Short InterestSqueeze Risk
Short % of Float?34.48%Squeeze Risk
Short Interest?63.3M
Days to Cover?4.8
Free Float183.6M
Avg Daily Volume13.3M
Settlement Date2026-06-30
Financial Health
Current Ratio?17.20Strong
Quick Ratio?17.20Strong
Cash Ratio?16.59Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?21.51HIGH▾
Peers100
S&P6
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-70.0CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-27.4%WEAK▾
S&P6
ROA?-25.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$2.2B
Fundamentals ratios updated end of day